» Articles » PMID: 31620475

Isolation of Umbilical Cord Mesenchymal Stem Cells Using Human Blood Derivatives Accompanied with Explant Method

Overview
Date 2019 Oct 18
PMID 31620475
Citations 9
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Mesenchymal stem cells (MSCs) are multipotent cells which can be isolated from many sources including umbilical cord. Isolation protocols are depended on either explant or enzymatic methods. Although fetal bovine serum (FBS) is used as a supplement in isolation and expansion of MSCs, human blood derivatives such as cord blood serum (CBS) and platelet lysate (PL) are attractive substitutes of FBS which overcome impediments of using FBS in clinical setups.

Methods: Here we compared the effect of using CBS, PL and FBS supplemented media in isolation of umbilical cord tissue derived MSCs by using explant method. To do that we cultured umbilical cord tissue explant in either CBS or PL or FBS supplemented media. Isolated cells were quantified, their morphology was assessed and Cells in passage 3 were characterized based on their immunophenotyping and their potential for differentiation into adipocytes and osteocytes. Moreover, proliferation of cells was assessed by crystal violet staining.

Results: All the three media succeeded to isolate MSCs and maintain their stemness characteristics. However, the highest number of isolated cells were obtained using CBS, ~10-fold more than FBS, while the number of isolated cells obtained using PL was ~2-fold more than FBS. Moreover, crystal violet showed that both PL and CBS promote proliferation of MSCs more than FBS.

Conclusions: Our data suggest that, although all supplements maintain stemness characteristics of MSCs when used to isolate those cells by explant method, using human blood derived supplements is more effective than FBS. In the same context CBS is more effective than PL.

Citing Articles

Chondrogenic Potential of Umbilical Cord-Derived Mesenchymal Stromal Cells: Insights and Innovations.

Jeyaraman N, Jeyaraman M, Muthu S, Balaji S, Ramasubramanian S, Patro B Indian J Orthop. 2024; 58(10):1349-1361.

PMID: 39324097 PMC: 11420429. DOI: 10.1007/s43465-024-01239-8.


Mesenchymal Stromal Cell-Based Products: Challenges and Clinical Therapeutic Options.

Mello D, Mesquita F, Silva Dos Santos D, Asensi K, Dias M, Campos de Carvalho A Int J Mol Sci. 2024; 25(11).

PMID: 38892249 PMC: 11173248. DOI: 10.3390/ijms25116063.


The comparison of adipose-derived stromal cells (ADSCs) delivery method in a murine model of hindlimb ischemia.

Pilny E, Czapla J, Drzyzga A, Smolarczyk R, Matuszczak S, Jarosz-Biej M Stem Cell Res Ther. 2024; 15(1):27.

PMID: 38303049 PMC: 10836003. DOI: 10.1186/s13287-024-03634-2.


Revolutionizing orofacial pain management: the promising potential of stem cell therapy.

Ren K, Vickers R, Murillo J, Ruparel N Front Pain Res (Lausanne). 2023; 4:1239633.

PMID: 38028430 PMC: 10679438. DOI: 10.3389/fpain.2023.1239633.


Regulation of self-renewal and senescence in primitive mesenchymal stem cells by Wnt and TGFβ signaling.

Mazzella M, Walker K, Cormier C, Kapanowski M, Ishmakej A, Saifee A Stem Cell Res Ther. 2023; 14(1):305.

PMID: 37880755 PMC: 10601332. DOI: 10.1186/s13287-023-03533-y.


References
1.
Lykov A, Bondarenko N, Surovtseva M, Kim I, Poveshchenko O, Pokushalov E . Comparative Effects of Platelet-Rich Plasma, Platelet Lysate, and Fetal Calf Serum on Mesenchymal Stem Cells. Bull Exp Biol Med. 2017; 163(6):757-760. DOI: 10.1007/s10517-017-3897-5. View

2.
Kinzebach S, Bieback K . Expansion of Mesenchymal Stem/Stromal cells under xenogenic-free culture conditions. Adv Biochem Eng Biotechnol. 2012; 129:33-57. DOI: 10.1007/10_2012_134. View

3.
Riis S, Nielsen F, Pennisi C, Zachar V, Fink T . Comparative Analysis of Media and Supplements on Initiation and Expansion of Adipose-Derived Stem Cells. Stem Cells Transl Med. 2016; 5(3):314-24. PMC: 4807663. DOI: 10.5966/sctm.2015-0148. View

4.
Yoon J, Roh E, Shin S, Jung N, Song E, Chang J . Comparison of explant-derived and enzymatic digestion-derived MSCs and the growth factors from Wharton's jelly. Biomed Res Int. 2013; 2013:428726. PMC: 3638666. DOI: 10.1155/2013/428726. View

5.
Mirabet V, Solves P, Minana M, Encabo A, Carbonell-Uberos F, Blanquer A . Human platelet lysate enhances the proliferative activity of cultured human fibroblast-like cells from different tissues. Cell Tissue Bank. 2007; 9(1):1-10. DOI: 10.1007/s10561-007-9048-x. View